Pancreatic Cystic Lesions (IPMN)
- A pancreatic cyst is a fluid-filled pocket in the pancreas. Most are found by accident, and the whole game is sorting the harmless ones from the ones that can turn into cancer.
- The crucial split is mucinous (can become malignant — IPMN and mucinous cystic neoplasm) vs non-mucinous (serous cystadenoma, pseudocyst — basically benign).
- IPMN's signature trick: it talks to the duct. A cyst that communicates with the pancreatic duct is the classic IPMN.
- The scary features ("worrisome" / "high-risk") are an enhancing mural nodule, a thick enhancing wall, a dilated main duct, and rapid growth. These push toward surgery or close follow-up.
- MRI with MRCP is the workhorse for characterizing and following these. EUS with fluid sampling settles the close calls.
Someone gets a CT for a kidney stone, and there at the edge of the report is a sentence nobody asked for: "incidental 1.2 cm cystic lesion in the pancreatic tail." Welcome to one of the most common "uh oh" findings in modern radiology. Pancreatic cysts are everywhere now, mostly because we scan everybody for everything. The good news is that the vast majority are lazy and harmless. The job is figuring out which ones aren't.
The one fork in the road: mucinous or not
If you remember one thing, make it this. Pancreatic cysts split into two camps, and the camps matter because one can turn into cancer and the other basically can't.
Mucinous cysts are lined by cells that make mucin (think: the slimy stuff). These have malignant potential. The two big names here are the IPMN (intraductal papillary mucinous neoplasm) and the mucinous cystic neoplasm (MCN).
Non-mucinous cysts are the calm ones: the serous cystadenoma (almost always benign) and the pseudocyst (a walled-off puddle left over after pancreatitis, not a tumor at all).
So the first question I ask every pancreatic cyst is the same one a bouncer asks: are you the kind that causes trouble?
What makes IPMN special: it's plugged into the plumbing
Here's the IPMN party trick. Picture the pancreatic duct as the main water line running through the gland. An IPMN grows from that ductal system, so the cyst is literally connected to the duct — fluid can flow between them. That communication with the pancreatic duct is the feature that screams IPMN, and it's exactly what MRCP is built to show.
We sort IPMNs by which pipe they involve:
| Type | What it involves | Why you care |
|---|---|---|
| Branch-duct | A side branch (often a cluster, "bunch of grapes") | Common, usually lower risk, often just watched |
| Main-duct | Dilation of the main pancreatic duct itself | Higher risk of malignancy — taken seriously |
| Mixed | Both | Treated like the main-duct (higher-risk) sibling |
A main-duct IPMN can make the whole duct look fat and dilated, sometimes with mucin oozing out a bulging papilla. That diffuse "garden hose left the tap on" duct dilation, with no stone or mass to explain it, should make you think IPMN rather than ordinary obstruction.
The serous decoy
The classic mimic is the serous cystadenoma — the benign one you don't want to cut out by mistake. Its giveaway is a microcystic, honeycomb pattern: a sponge full of tiny cysts, sometimes with a central scar that can calcify. When you see that spongy honeycomb with a central scar, you can usually relax.
A serous cystadenoma packed with tiny cysts can look almost solid on CT, because all those tiny walls blur together — and "solid pancreatic mass" sends everyone into a panic. MRI and its long T2 sequences re-reveal the fluid and the honeycomb, talking everyone back off the ledge.
The features that change the plan
When characterizing a mucinous cyst, you're hunting for signs it's getting ambitious. The high-risk and "worrisome" features in mainstream guidelines cluster around the same ideas:
| Feature | Why it's worrying |
|---|---|
| Enhancing mural nodule / solid component | Soft tissue that takes up contrast = real cells growing, not just fluid. The single most important red flag. |
| Main pancreatic duct dilation | Suggests main-duct involvement; the more dilated, the more concern. |
| Thick, enhancing wall or septa | Beefy walls suggest something more than a quiet cyst. |
| Large size / rapid growth | Bigger and faster-growing cysts get more attention and shorter leashes. |
| Obstructive jaundice from the lesion | A cyst in the head causing jaundice is taken seriously. |
The mural nodule is the one to never miss. A small bump on the inner wall that enhances after contrast is the difference between "watch this" and "this needs tissue or surgery." On MRI, look at the post-contrast and DWI images, not just the pretty fluid-bright T2.
How we actually image and follow them
MRI with MRCP is the star. The heavily T2-weighted MRCP sequence lights up fluid so brilliantly that it maps the cyst, the duct, and — critically — whether they're holding hands. It's also radiation-free, which matters because these get followed for years.
CT characterizes well and shows calcification beautifully (helpful for the serous central scar), but it's worse at proving duct communication. EUS (endoscopic ultrasound) is the tiebreaker: it gets a probe millimeters away and can aspirate cyst fluid. High fluid CEA points toward mucinous; high amylase points toward duct communication (IPMN or a pseudocyst).
Before you call any pancreatic cyst a "pseudocyst," make sure there's a pancreatitis story. Calling a mucinous neoplasm a pseudocyst because it was convenient is a classic, consequential miss — one is a puddle, the other is a slow-motion cancer.
The bottom line
When you see a pancreatic cyst, run the same loop every time: Is it mucinous (dangerous family) or not? Does it communicate with the duct (IPMN)? And are there worrisome features — especially an enhancing nodule or a dilated main duct? That triage decides whether the cyst earns a calm follow-up MRI, an EUS, or a trip to a surgeon — and keeps it from quietly graduating into pancreatic adenocarcinoma while nobody was watching.